Heading into the 2022–23 respiratory season, hospitals — especially pediatric units — faced a wave of overlapping viral illness unlike anything in recent memory. RSV, influenza, and COVID-19 surged simultaneously, in what came to be called the "tripledemic."
Why all three at once
Pandemic-era distancing and masking suppressed circulation of RSV and seasonal influenza for nearly two years. That kept short-term case counts low but also depressed population immunity. When restrictions eased, both viruses returned vigorously — at the same time COVID-19 continued to circulate.
The downstream effects
Hospitals saw bed shortages, staffing strain, and a sharp increase in pediatric ICU admissions for RSV-driven respiratory failure. Less visibly, viral illness frequently triggers empirical antibiotic prescribing — even though antibiotics do nothing against viruses. That overuse continues to push antimicrobial resistance upward, on top of the AMR acceleration already documented during the pandemic.
What helps
Continued public-health basics
Vaccination (where available), good ventilation, hand hygiene, and staying home when sick still substantially reduce transmission of respiratory viruses.
Viral surveillance
Sequencing-based surveillance of circulating viruses helps public health agencies track variants, predict surges, and target interventions.
Precision diagnostics at the point of care
Multiplex molecular tests that quickly distinguish viral from bacterial respiratory illness are one of the most effective ways to reduce unnecessary antibiotic prescribing — and to make sure the patients who do need antibiotics get the right ones, an issue that becomes critical when infections progress to sepsis.
The bigger lesson
Overlapping outbreaks are likely to recur. Building the diagnostic and surveillance infrastructure to respond to them — without resorting to broad empirical prescribing — is one of the most durable investments healthcare systems can make.
Frequently asked questions
What is the tripledemic?
It's the term used for the simultaneous surge of three respiratory viruses — RSV, influenza, and SARS-CoV-2 — that hit hospitals and pediatric care especially hard following relaxed pandemic restrictions.
Why did it happen?
Pandemic-era distancing and masking suppressed circulation of RSV and influenza, leaving population immunity unusually low. When restrictions eased, both viruses returned with high force alongside ongoing COVID-19 transmission.
What does this have to do with antibiotic resistance?
Viral respiratory illness frequently leads to empirical antibiotic prescribing — even though antibiotics don't treat viruses. That overuse drives antimicrobial resistance, particularly when diagnostics aren't fast enough to confirm whether bacteria are actually involved.